Related Experiment Video

Updated: Jul 10, 2026

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
13:08

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay

Published on: September 9, 2012

[Congenital defects of antithrombin III and proteins C and S during pregnancy]

R Enríquez1, C Rondini, A Sánchez

  • 1Departamento de Obstetricia y Ginecología, Escuela de Medicina, Pontificia Universidad Católica de Chile.

Revista Medica De Chile
|August 7, 1999
PubMed

Insights

This study focuses on congenital deficiencies in natural anticoagulant proteins (Protein S, Protein C, and antithrombin III) and their impact on pregnancy outcomes. Management strategies for thrombophilia during pregnancy are discussed.

Area of Science:

  • Hematology
  • Obstetrics
  • Genetics

Context:

  • Congenital deficiencies in natural anticoagulant proteins (Protein S, Protein C, antithrombin III) are rare but significant risk factors for thrombosis.
  • Pregnancy significantly increases thrombotic risk due to physiological changes.

Purpose:

  • To report on 10 patients with congenital deficiencies of anticoagulant proteins.
  • To discuss the management of thrombophilia during pregnancy, delivery, and perinatal outcomes.
  • To review the role of these proteins in thrombotic events and complications.

Summary:

  • Ten patients with congenital deficiencies of Protein S, Protein C, and antithrombin III were identified.
  • Thirteen pregnancies among these patients were managed, with a focus on thrombotic complications.
  • Guidelines for investigating and managing congenital thrombophilia during pregnancy are presented.

Impact:

  • Informs clinical practice regarding the management of pregnant patients with congenital thrombophilia.
  • Highlights the importance of understanding anticoagulant protein function in preventing pregnancy-related thrombotic events.
  • Contributes to improved perinatal outcomes for women with inherited thrombophilias.

More Related Videos

Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound (30/45MHZ) System07:34

Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound (30/45MHZ) System

Published on: May 5, 2018

Analysis of Congenital Heart Defects in Mouse Embryos Using Qualitative and Quantitative Histological Methods08:28

Analysis of Congenital Heart Defects in Mouse Embryos Using Qualitative and Quantitative Histological Methods

Published on: March 10, 2020

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Rh Blood Group01:19

Rh Blood Group

The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...